Economic Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review
Tuberculosis and Respiratory Diseases · 01.07.2024 · 87 (3) · 234-251
DOI: 10.4046/trd.2023.0100 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Tuberculosis and Respiratory Diseases, erschienen am 01.07.2024. Verfasst von Hai Quang Pham und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vingroup Innovation Foundation, National Cancer Center.
Themen: COPD
Abstract (Originalsprache)
Globally, providing evidence on the economic burden of chronic obstructive pulmonary disease (COPD) is becoming essential as it assists the health authorities to efficiently allocate resources. This study aimed to summarize the literature on economic burden evidence for COPD from 1990 to 2019. This study examined the economic burden of COPD through a systematic review of studies from 1990 to 2019. A search was done in online databases, including Web of Science, PubMed/Medline, Scopus, and the Cochrane Library. After screening 12,734 studies, 43 articles that met the inclusion criteria were identified. General study information and data on direct, indirect, and intangible costs were extracted and converted to 2018 international dollars (Int$). Findings revealed that the total direct costs ranged from Int$ 52.08 (India) to Int$ 13,776.33 (Canada) across 16 studies, with drug costs rannging from Int$ 70.07 (Vietnam) to Int$ 8,706.9 (China) in 11 studies. Eight studies explored indirect costs, while one highlighted caregivers’ direct costs at approximately Int$ 1,207.8 (Greece). This study underscores the limited research on COPD caregivers’ economic burdens, particularly in developing countries, emphasizing the importance of increased research support, particularly in high-resource settings. This study provides information about the demographics and economic burden of COPD from 1990 to 2019. More strategies to reduce the frequency of hospital admissions and acute care services should be implemented to improve the quality of COPD patients’ lives and reduce the disease’s rising economic burden.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Economics, School of Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.
- Institute of Theoretical and Applied Research, Duy Tan University, Danang, Vietnam.
- School of Business and Economics, Duy Tan University, Danang, Vietnam.
- Can Tho University of Medicine and Pharmacy, Faculty of Public Health, Can Tho, Vietnam.
- Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.
Förderung
- Vingroup Innovation Foundation
- National Cancer Center
Zitieren
APA
Pham, H. Q., Pham, K. H. T., Ha, G. H., Pham, T. T., Nguyen, H. T., Nguyen, T. H. T., & Oh, J. K. (2024). Economic Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and Respiratory Diseases, 87(3), 234-251. https://doi.org/10.4046/trd.2023.0100
Vancouver
Pham HQ, Pham KHT, Ha GH, Pham TT, Nguyen HT, Nguyen THT, et al. Economic Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and Respiratory Diseases. 2024;87(3):234-251. doi:10.4046/trd.2023.0100
BibTeX
@article{Pham2024,
author = {Pham, Hai Quang and Pham, Kiet Huy Tuan and Ha, Giang Hai and Pham, Tin Trung and Nguyen, Hien Thi and Nguyen, Trang Huyen Thi and Oh, Jin-Kyoung},
title = {Economic Burden of Chronic Obstructive Pulmonary Disease: A Systematic Review},
journal = {Tuberculosis and Respiratory Diseases},
year = {2024},
volume = {87},
number = {3},
pages = {234--251},
doi = {10.4046/trd.2023.0100}
}
EUVIMED